全球內視鏡超音波市場規模依產品類型、應用、最終用戶、地區、範圍和預測

內視鏡超音波市場規模及預測

2024 年內視鏡超音波市場規模價值 11.8 億美元，預計到 2032 年將達到 18.7 億美元，2026 年至 2032 年的複合年成長率為 6.5%。

內視鏡超音波(EUS) 是一種使用內視鏡和超音波獲取消化道及周圍組織和器官的詳細影像的醫療程序，為診斷和治療目的提供高解析度影像。

超音波超音波廣泛用於診斷和分期胃腸道（GI）癌症，包括食道癌、胰臟癌和大腸癌。

它也用於評估胰臟炎、膽結石、囊腫等良性疾病。 EUS 允許使用細針抽吸 (FNA) 獲取組織樣本進行切片檢查，有助於準確診斷和治療計劃。

其他治療應用包括胰臟假性囊腫引流、腹腔神經叢神經鬆弛以控制疼痛、以及引導注射和放置支架。

內視鏡超音波的前景光明，預計技術進步將增強診斷和治療能力。

全球內視鏡超音波市場動態

關鍵市場促進因素

胃腸道疾病盛行率不斷上升：胃腸道癌症和其他胃腸道疾病盛行率的不斷上升，推動了對內視鏡超音波(EUS) 等先進診斷工具的需求，以便早期發現並改善治療效果。根據美國國家癌症研究所的數據，大腸直腸癌是美國第三大常見癌症，預計2022年將新增151,030例。

技術進步：EUS 設備的持續創新，例如高解析度成像和微創技術，正在提高診斷準確性並擴大治療應用範圍，從而推動市場成長。美國食品藥物管理局(FDA) 將在 2024 年核准12 種新型內視鏡設備，與前一年同期比較成長 20%，凸顯了該領域創新的快速步伐。

微創手術的普及率不斷提升：由於人們更傾向於微創診斷和治療手術，以縮短患者康復時間並降低相關風險，EUS 在臨床實踐中的應用正在加速。美國醫療保險和醫療補助服務中心 (CMS) 報告顯示，從 2020 年到 2024 年，門診內視鏡手術數量將增加 15%，這反映了這一趨勢。 EUS 手術可以縮短患者康復時間並降低相關風險，因此越來越受歡迎。

老年人口不斷成長：全球人口老化將導致與老齡化相關的胃腸道疾病的盛行率上升，需要像EUS這樣的先進診斷程序來有效管理和治療。世界衛生組織（WHO）預測，2015年至2050年期間，全球60歲以上人口的比例將幾乎加倍，從12%增加到22%。預計這項人口結構變化將推動EUS的需求。

醫療保健支出成長：醫療保健支出成長，尤其是在發展中地區，將促進先進醫療技術的採用和普及，包括超音波內視鏡（EUS），從而改善優質診斷和治療服務的可近性。世界銀行報告稱，全球醫療保健支出佔GDP的比例將從2010年的9.7%上升到2022年的10.2%，顯示對醫療保健服務和科技的投資正在不斷成長。這一趨勢正在改善優質診斷和治療服務的可近性。

主要挑戰

缺乏訓練有素的專業人員：EUS 程序的複雜性需要專門的培訓和專業知識，而缺乏經過充分培訓的專業人員可能會阻礙該技術的市場成長和廣泛採用。

嚴格的監管要求：嚴格的核准流程和監管標準的遵守可能會減緩新的 EUS 設備和技術的引入，從而影響市場擴張和創新。

併發症和副作用的風險：儘管 EUS 是一種微創技術，但它確實存在感染、出血和穿孔等風險，這可能會阻止患者和提供者選擇這種診斷程序。

來自替代成像方式的競爭：其他先進影像技術（如 MRI 和電腦斷層掃描）的可用性，可有效診斷胃腸道疾病，可能會限制對 EUS 的需求並影響市場成長。

主要趨勢

人工智慧 (AI) 的整合：將人工智慧和機器學習融入 EUS 系統，以增強影像分析和解讀，提高診斷準確性和效率，並制定更精準、更個人化的治療方案，這一趨勢正在加速發展。美國國立衛生研究院 (NIH) 於 2024 年報告稱，與傳統方法相比，人工智慧輔助 EUS 診斷可將早期胰臟癌的檢出率提高 15%。近期，Olympus Corporation於 2024 年 7 月 10 日宣布推出一款搭載人工智慧的全新 EUS 平台，預計將手術時間縮短 30%，並提高病變檢出率。

設備小型化：EUS 探頭和儀器體積越來越小，降低了操作的創傷性，並提高了患者的舒適度。歐洲胃腸內視鏡學會 (ESGE) 於 2024 年報告稱，過去五年內，EUS 探頭的平均直徑減小了 25%，顯著降低了患者的不適感。這一趨勢正在擴大 EUS 的應用範圍，尤其是在門診病人中。

擴大治療應用：EUS 的應用範圍不僅限於診斷，還日益廣泛地應用於標靶藥物、囊腫引流和腫瘤切除等治療性介入，這正在擴大其臨床效用，並推動市場成長。根據美國胃腸內視鏡學會 (ASGE) 的報告，EUS 引導下的干涉措施在 2019 年至 2024 年間將增加 40%，其中囊腫引流和腫瘤切除等手術的增幅最高。

目錄

第1章 引言

• 市場定義
• 市場區隔
• 調查方法

第2章執行摘要

• 主要發現
• 市場概覽
• 市場亮點

第3章市場概述

• 市場規模和成長潛力
• 市場趨勢
• 市場促進因素
• 市場限制
• 市場機會
• 波特五力分析

第4章內視鏡超音波市場（依產品類型）

• 放射狀內超音波超音波檢查（EUS）
• 線性內視鏡超音波（EUS）
• 凸面內視鏡超音波（EUS）
• 相位陣列超音波（EUS）
• 多普勒超音波超音波（EUS）

第5章內視鏡超音波市場（依應用）

• 消化系統
• 腫瘤學
• 呼吸系統醫療設備
• 婦科
• 泌尿系統

第6章內視鏡超音波市場（依最終用戶）

• 醫院
• 門診手術中心（ASC）
• 診斷中心
• 診所

第7章區域分析

• 北美洲
• 美國
• 加拿大
• 墨西哥
• 歐洲
• 英國
• 德國
• 法國
• 義大利
• 亞太地區
• 中國
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中東和非洲
• 南非
• 沙烏地阿拉伯
• 阿拉伯聯合大公國

第8章市場動態

• 市場促進因素
• 市場限制
• 市場機會
• COVID-19 市場影響

第9章 競爭態勢

• 主要企業
• 市場佔有率分析

第10章 公司簡介

• Olympus Corporation
• PENTAX Medical（HOYA Corporation）
• FUJIFILM Corporation
• Hitachi Medical Systems
• Boston Scientific Corporation
• Cook Medical
• Medtronic
• CONMED Corporation
• Medi-Globe GmbH
• Limaca Medical

第11章 市場展望與機會

• 新興技術
• 未來市場趨勢
• 投資機會

第12章 附錄

• 簡稱列表
• 來源和參考文獻

Endoscopy Ultrasound Market Size And Forecast

Endoscopy Ultrasound Market size was valued at USD 1.18 Billion in 2024 and is projected to reach USD 1.87 Billion by 2032, growing at a CAGR of 6.5% from 2026 to 2032.

Endoscopic ultrasound (EUS) is a medical procedure that uses an endoscope and ultrasound to obtain detailed images of the digestive tract and surrounding tissues and organs, providing high-resolution imaging for diagnostic and therapeutic purposes.

Endoscopic ultrasound is widely used in the diagnosis and staging of gastrointestinal (GI) cancers, such as esophageal, pancreatic, and colorectal cancers.

It is also employed to evaluate benign conditions like pancreatitis, gallstones, and cysts. EUS enables fine-needle aspiration (FNA) to obtain tissue samples for biopsy, aiding in accurate diagnosis and treatment planning.

Additionally, therapeutic applications include drainage of pancreatic pseudocysts, celiac plexus neurolysis for pain management, and guided injections or placements of stents.

The future of endoscopic ultrasound is promising due to anticipated technological advancements that will enhance its diagnostic and therapeutic capabilities.

Global Endoscopy Ultrasound Market Dynamics

The key market dynamics that are shaping the global endoscopy ultrasound market include:

Key Market Drivers

Increasing Prevalence of Gastrointestinal Diseases: The rising incidence of GI cancers and other digestive disorders drives demand for advanced diagnostic tools like endoscopic ultrasound (EUS) to improve early detection and treatment outcomes. According to the National Cancer Institute, colorectal cancer is the third most common cancer in the United States, with an estimated 151,030 new cases in 2022.

Technological Advancements: Continuous innovations in EUS equipment, such as high-resolution imaging and minimally invasive techniques, enhance diagnostic accuracy and broaden the range of therapeutic applications, boosting market growth. The U.S. Food and Drug Administration (FDA) approved 12 new endoscopic devices in 2024, a 20% increase from the previous year, highlighting the rapid pace of innovation in this field.

Growing Adoption of Minimally Invasive Procedures: The preference for minimally invasive diagnostic and therapeutic procedures, which reduce patient recovery time and associated risks, fuels the adoption of EUS in clinical settings. The Centers for Medicare & Medicaid Services reported a 15% increase in outpatient endoscopic procedures between 2020 and 2024, reflecting this trend. EUS procedures, which reduce patient recovery time and associated risks, are becoming increasingly popular.

Rising Geriatric Population: An aging global population increases the prevalence of age-related gastrointestinal conditions, necessitating advanced diagnostic procedures like EUS for effective management and treatment. The World Health Organization projects that the proportion of the world's population over 60 years will nearly double from 12% to 22% between 2015 and 2050. This demographic shift is expected to drive demand for EUS procedures.

Increasing Healthcare Expenditure: Higher healthcare spending, particularly in developing regions, supports the adoption and implementation of advanced medical technologies, including EUS, improving access to quality diagnostic and therapeutic services. The World Bank reported that global health expenditure as a percentage of GDP increased from 9.7% in 2010 to 10.2% in 2022, indicating growing investment in healthcare services and technologies. This trend is improving access to quality diagnostic and therapeutic services.

Key Challenges:

Limited Availability of Skilled Professionals: The complexity of EUS procedures necessitates specialized training and expertise, and the shortage of adequately trained professionals can hinder market growth and the widespread adoption of this technology.

Stringent Regulatory Requirements: The rigorous approval processes and compliance with strict regulatory standards can delay the introduction of new EUS devices and technologies, impacting market expansion and innovation.

Risk of Complications and Adverse Effects: Although minimally invasive, EUS procedures carry risks such as infection, bleeding, and perforation, which may deter patients and healthcare providers from opting for this diagnostic method.

Competition from Alternative Imaging Modalities: The availability of other advanced imaging technologies, such as MRI and CT scans, which are also effective in diagnosing GI conditions, can limit the demand for EUS, affecting market growth.

Key Trends

Integration of Artificial Intelligence (AI): AI and machine learning are being increasingly integrated into EUS systems to enhance image analysis and interpretation, improving diagnostic accuracy and efficiency, and enabling more precise and personalized treatment plans. The National Institutes of Health (NIH) reported in 2024 that AI-assisted EUS diagnoses showed a 15% improvement in early pancreatic cancer detection compared to traditional methods. In a recent development, on July 10, 2024, Olympus Corporation announced the launch of its new AI-powered EUS platform, promising a 30% reduction in procedure time and improved lesion detection rates.

Miniaturization of Equipment: Ongoing advancements in the miniaturization of EUS probes and devices are making procedures less invasive and more comfortable for patients, expanding the range of applications and facilitating adoption in outpatient settings. The European Society of Gastrointestinal Endoscopy (ESGE) reported in 2024 that the average diameter of EUS probes decreased by 25% over the past five years, significantly reducing patient discomfort. This trend has expanded the range of EUS applications, particularly in outpatient settings.

Expansion of Therapeutic Applications: Beyond diagnostics, EUS is increasingly being utilized for therapeutic interventions, such as targeted drug delivery, cyst drainage, and tumor ablation, broadening its clinical utility and driving market growth. The American Society for Gastrointestinal Endoscopy (ASGE) reported that EUS-guided interventions increased by 40% between 2019 and 2024, with procedures like cyst drainage and tumor ablation seeing the highest growth.

Global Endoscopy Ultrasound Market Regional Analysis

Here is a more detailed regional analysis of the global endoscopy ultrasound market:

North America

North America dominating the endoscopy ultrasound market due to advanced healthcare infrastructure, high adoption rates of innovative medical technologies, and a large pool of skilled professionals. According to the Centers for Disease Control and Prevention (CDC), gastrointestinal diseases affected approximately 70 million Americans in 2022, underscoring the growing need for advanced diagnostic and therapeutic tools like EUS.

The increasing prevalence of gastrointestinal diseases and robust healthcare expenditure further drive market growth in this region. The Centers for Medicare & Medicaid Services (CMS) reported that U.S. healthcare spending reached USD 4.3 Trillion in 2024, with a notable portion allocated to advanced medical technologies like EUS. This substantial investment has facilitated the widespread adoption of cutting-edge EUS systems across healthcare institutions.

Government initiatives and funding for cancer research also contribute to the expanding use of EUS. For instance, in July 20, 2024, Pentax Medical, a key player in the EUS market, announced a partnership with a leading U.S. cancer research institute to develop a novel EUS-guided drug delivery system for pancreatic cancer treatment. This collaboration exemplifies the ongoing efforts to leverage EUS technology in advancing cancer care and solidifies North America's position at the forefront of EUS market growth.

Asia Pacific

The Asia-Pacific region is witnessing rapid growth in the endoscopic ultrasound (EUS) market, driven by substantial healthcare investments and an increasing prevalence of gastrointestinal disorders. According to the World Health Organization (WHO), healthcare spending in the Western Pacific region, which includes much of Asia, reached 6.6% of GDP in 2022, marking a significant increase from previous years.

This rising investment has directly contributed to improving healthcare infrastructure and the adoption of advanced medical technologies like EUS. The Asian Pacific Society for Digestive Endoscopy reported a 45% increase in EUS procedures across the region from 2020 to 2024, highlighting the growing acceptance and utilization of this technology.

China, Japan, and India are spearheading the expansion of the EUS market in the Asia-Pacific region. China's National Health Commission reported that the country's healthcare expenditure reached 7.12 trillion yuan (approximately USD 1.1 Trillion) in 2024, with a substantial portion allocated to upgrading medical equipment in hospitals.

The growing middle-class population and rising disposable incomes in the Asia-Pacific region are fueling the demand for advanced medical diagnostics and treatments. The Asian Development Bank estimated that 65% of the region's population will be middle class by 2025, up from 45% in 2015. This demographic shift has led to increased healthcare awareness and willingness to invest in advanced medical procedures.

Global Endoscopy Ultrasound Market: Segmentation Analysis

The Global Endoscopy Ultrasound Market is Segmented on the basis of Product Type, Application, End-User, and Geography.

Endoscopy Ultrasound Market, By Product Type

• Radial-Endoscopic Ultrasound (EUS)
• Linear-Endoscopic Ultrasound (EUS)
• Curvilinear-Endoscopic Ultrasound (EUS)
• Phased Array-Endoscopic Ultrasound (EUS)
• Doppler-Endoscopic Ultrasound (EUS)

Based on Product Type, the Global Endoscopy Ultrasound Market is bifurcated into Radial-Endoscopic Ultrasound (EUS), Linear-Endoscopic Ultrasound (EUS), Curvilinear-Endoscopic Ultrasound (EUS), Phased Array-Endoscopic Ultrasound (EUS), and Doppler-Endoscopic Ultrasound (EUS). In the endoscopy ultrasound (EUS) market, linear-endoscopic ultrasound (EUS) is currently the dominant product type due to its widespread use in gastrointestinal diagnostics, providing detailed images for precise assessments of digestive tract conditions. Radial-endoscopic ultrasound (EUS) is the second rapidly growing segment, driven by its ability to offer comprehensive views of the surrounding structures, making it increasingly popular for evaluating pancreatic and bile duct conditions. Both product types are essential for enhancing diagnostic accuracy and are witnessing growth due to advancements in technology and increasing clinical applications.

Endoscopy Ultrasound Market, By Application

• Gastroenterology
• Oncology
• Pulmonology
• Gynecology
• Urology

Based on Application, the Global Endoscopy Ultrasound Market is bifurcated into Gastroenterology, Oncology, Pulmonology, Gynecology, and Urology. In the endoscopy ultrasound (EUS) market, gastroenterology is the dominant application due to its extensive use in diagnosing and managing gastrointestinal conditions, such as cancers, pancreatitis, and bile duct abnormalities. Oncology is the second rapidly growing application, driven by the increasing need for precise staging and diagnosis of cancers, particularly in organs such as the pancreas and rectum, where EUS provides critical imaging for effective treatment planning and monitoring. Both applications are crucial in advancing diagnostic capabilities and improving patient outcomes in their respective fields.

Endoscopy Ultrasound Market, By End-User

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Diagnostic Centers
• Clinics

Based on End-User, the Global Endoscopy Ultrasound Market is bifurcated into Hospitals, Ambulatory Surgical Centers (ASCs), Diagnostic Centers, and Clinics. In the endoscopy ultrasound (EUS) market, hospitals are the dominant end-user due to their comprehensive facilities and high volume of diagnostic and therapeutic procedures, which leverage EUS technology for advanced patient care. Ambulatory Surgical Centers (ASCs) are the second rapidly growing end-user, driven by the increasing preference for outpatient procedures and the need for minimally invasive diagnostics and treatments. ASCs offer a convenient and cost-effective setting for EUS procedures, contributing to their expanding role in the market.

Endoscopy Ultrasound Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on Geography, the Global Endoscopy Ultrasound Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. In the endoscopy ultrasound (EUS) market, North America is the dominant region, driven by its advanced healthcare infrastructure, high adoption of innovative medical technologies, and substantial healthcare expenditure. Asia-Pacific is the second rapidly growing region, fueled by increasing healthcare investments, rising prevalence of gastrointestinal disorders, and expanding healthcare infrastructure in countries like China, Japan, and India. The rapid growth in Asia-Pacific is supported by a rising middle-class population and greater accessibility to advanced medical diagnostics.

Key Players

The "Global Endoscopy Ultrasound Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Olympus Corporation, PENTAX Medical (HOYA Corporation), FUJIFILM Corporation, Hitachi Medical Systems, Boston Scientific Corporation, Cook Medical, Medtronic, CONMED Corporation, Medi-Globe GmbH, Limaca Medical.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Global Endoscopy Ultrasound Market Key Developments

• In September 2024, Olympus Corporation introduced the UEV-400, a next-generation endoscopic ultrasound system featuring enhanced imaging resolution and real-time 3D visualization capabilities, aimed at improving diagnostic accuracy in gastrointestinal procedures.
• In June 2024, Fujifilm unveiled the EG-740UT, a new endoscopic ultrasound device with advanced needle guidance technology, designed to facilitate more precise biopsies and reduce procedure time in oncology applications.
• In March 2024, Pentax Medical announced a major upgrade to its EUS system with the release of the i-scan 3D, which integrates artificial intelligence to enhance image clarity and assist in the early detection of abnormalities.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Endoscopy Ultrasound Market, By Product Type

• Radial-Endoscopic Ultrasound (EUS)
• Linear-Endoscopic Ultrasound (EUS)
• Curvilinear-Endoscopic Ultrasound (EUS)
• Phased Array-Endoscopic Ultrasound (EUS)
• Doppler-Endoscopic Ultrasound (EUS)

5. Endoscopy Ultrasound Market, By Application

• Gastroenterology
• Oncology
• Pulmonology
• Gynecology
• Urology

6. Endoscopy Ultrasound Market, By End-User

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Diagnostic Centers
• Clinics

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Olympus Corporation
• PENTAX Medical (HOYA Corporation)
• FUJIFILM Corporation
• Hitachi Medical Systems
• Boston Scientific Corporation
• Cook Medical
• Medtronic
• CONMED Corporation
• Medi-Globe GmbH
• Limaca Medical

11. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References